Not medical advice. SS-31 is sold for research. This guide does not recommend dosing, diagnosis, or therapy.
SS-31 is listed in our catalogue under “Metabolic / Longevity.” In scientific publications it is discussed in technical language; this page translates the general themes into everyday wording while staying faithful to research-only framing.
One-paragraph overview from our research datasheet, still scientific, but faster to read than the full mechanism list below.
SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, binds cardiolipin, and restores electron transport chain efficiency in models of mitochondrial dysfunction.
Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss, cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.
“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.
Researchers study these compounds for mitochondrial function, nutrient sensing, and cellular energy stress responses -often in ageing or metabolic disease models.
Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.
Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from light. Use within the validated stability window for the specific batch and formulation. - see our storage guide for best practices on temperature, light, and shelf life.
Typical research dosing discussion (literature-style): 3–5 mg subcutaneous or intravenous injection · Once daily for acute models; 3×/week for chronic protocols · SS-31 is rapidly cleared from plasma (t½ ~2 h in rodents) but accumulates and is retained in mitochondria-rich tissues for extended periods. Subcutaneous dosing is standard in chronic preclinical studies; IV bolus is used in acute ischaemia–reperfusion models. No published human PK data exists outside of the clinical-trial context (elamipretide cardiac and renal indications).
For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes, and always verify batch purity by reading the COA.
Other compounds researchers often read about alongside SS-31.
What is SS-31 in plain language?
SS-31 is a research peptide we catalogue under “Metabolic / Longevity.” This article explains how scientists discuss it in published literature and what study types usually appear, not as a consumer product claim.
Does this page give medical advice or dosing instructions for SS-31?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.
Where can I see purity, variants, and pricing for SS-31?
Use the “View product” button to open the canonical shop listing for SS-31, where specifications and research SKU details are shown.
What about online case reports, before-and-after stories, or forum “logs” for SS-31?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.
Primary literature and registries for SS-31, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Open the shop listing for variants, purity notes, and research SKU details.
View productAlso known as: SS-31, Elamipretide, MTP-131, Bendavia, D-Arg-Dmt-Lys-Phe-NH2, Szeto-Schiller Peptide 31, SS31, Cardiolipin Binder